Home

NV QIAGEN

CIK 1015820 · last filed 2017-11-07

NV QIAGEN is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HTGM, was dated Nov 7, 2017. Across all open-market trades the lifetime net is +$173.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $255.3M across reported positions. The firm reports its address in Pl Venlo. 7 SEC filings were submitted jointly with WELLINGTON MANAGEMENT CO LLP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$255.30M

Companies

2

Total Filings

9

Lifetime Open-Market Net

$173.4K

Filer Profile

Reported Address
HULSTERWEG 82
PL VENLO 5912 PL
Phone
31-77-35566-00
State of Incorporation
Netherlands
Formerly Known As
QIAGEN NV (1998–2020)
Related Filers
WELLINGTON MANAGEMENT CO LLP — 7 joint filings, latest 2026-02-10
FRANKLIN RESOURCES INC — 6 joint filings, latest 2019-01-28
DEUTSCHE BANK AG\ — 5 joint filings, latest 2002-02-13
ALAFI CAPITAL CO LLC — 2 joint filings, latest 2004-02-13
Thierry Bernard — 1 joint filings, latest 2025-08-15
BlackRock Inc. — 1 joint filings, latest 2024-01-23
BlackRock, Inc. — 1 joint filings, latest 2026-02-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted 10%+ Owner — $0.48 — $0 1 2017-11-07
QGEN 10%+ Owner 6,006,996 $42.50 $255.30M $173.4K 8 2007-06-19

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-11-07 HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Buy (P) — $0 EDGAR
2007-06-19 QGEN Buy (P) +10,000 $13.5K EDGAR
2007-06-14 QGEN Buy (P) +10,000 $12.9K EDGAR
2007-06-06 QGEN Buy (P) +50,000 $65.5K EDGAR
2007-06-04 QGEN Buy (P) +5,000 $6.5K EDGAR
2007-05-31 QGEN Buy (P) +40,000 $52.4K EDGAR
2007-05-25 QGEN Buy (P) +17,500 $22.6K EDGAR
2007-05-09 QGEN Mixed +240,000 $108.0K EDGAR
2007-05-03 QGEN Mixed +340,000 $153.0K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.